Envestnet Portfolio Solutions Inc. Purchases 49,766 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Envestnet Portfolio Solutions Inc. raised its position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 76.9% in the fourth quarter, HoldingsChannel reports. The fund owned 114,502 shares of the company’s stock after acquiring an additional 49,766 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in SPDR S&P Pharmaceuticals ETF were worth $4,922,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. Stifel Financial Corp bought a new stake in shares of SPDR S&P Pharmaceuticals ETF in the third quarter valued at approximately $337,000. JPMorgan Chase & Co. boosted its stake in shares of SPDR S&P Pharmaceuticals ETF by 36.2% in the third quarter. JPMorgan Chase & Co. now owns 4,443 shares of the company’s stock valued at $197,000 after buying an additional 1,182 shares during the period. Jones Financial Companies Lllp boosted its stake in shares of SPDR S&P Pharmaceuticals ETF by 146.4% in the fourth quarter. Jones Financial Companies Lllp now owns 993 shares of the company’s stock valued at $43,000 after buying an additional 590 shares during the period. Sigma Planning Corp bought a new stake in shares of SPDR S&P Pharmaceuticals ETF in the fourth quarter valued at approximately $221,000. Finally, Arlington Financial Advisors LLC bought a new stake in shares of SPDR S&P Pharmaceuticals ETF in the fourth quarter valued at approximately $291,000.

SPDR S&P Pharmaceuticals ETF Stock Performance

Shares of XPH stock opened at $43.71 on Wednesday. SPDR S&P Pharmaceuticals ETF has a 1 year low of $38.88 and a 1 year high of $48.76. The stock has a market cap of $157.36 million, a P/E ratio of 15.01 and a beta of 0.72. The stock has a 50 day simple moving average of $44.34 and a 200 day simple moving average of $44.75.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.